Herpes simplex virus encephalitis in children.
Herpes simplex encephalitis (HSE) is an uncommon disease, yet 25 to 30 per cent of cases involve children. The initial clinical findings are nonspecific (fever, altered mental status), but most cases evolve to demonstrate focal neurologic signs and symptoms. The CSF is abnormal in over 90 per cent of cases. The EEG, CT, and MRI will further help in detecting focal encephalitis. The clinician caring for a child with focal encephalitis should institute broad-spectrum antimicrobial therapy plus acyclovir, pending definitive diagnosis by ancillary tests or brain biopsy, which is positive for HSE 33 to 55 per cent of the time and is diagnostic for other treatable conditions 10 to 20 per cent of the time. Acyclovir is the drug of choice for HSE and substantially reduces mortality and morbidity. The management of HSE in a child requires an experienced team of specialists and laboratory support in a tertiary intensive care setting.
Kohl
S
S
Department of Pediatrics, University of Texas Medical School, Houston.
D000212:Acyclovir / Q000627:therapeutic use; D002648:Child; D004660:Encephalitis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D006561:Herpes Simplex / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D014740:Vidarabine / Q000627:therapeutic use
D014740:Vidarabine; D000212:Acyclovir